and severe GI adverse reactions were reported more frequently among patients who received semaglutide tablets (7 mg 0.6%, 14 mg 2%) than placebo (0.3%)
The following points are essential to understand before interpreting the research data
Tran carefully evaluates your health history, diet, and lab results to tailor your dosage and frequency
Future trials should also measure important outcomes such as the clinical signs and symptoms of vitamin B 12 deficiency, health related-quality of life, socioeconomic effects, and report adverse events adequately, preferably in a primary care setting. Clinical practice guidelines British Columbia Medical Services Commission (MSC)
Available at: Hartman TJ, Woodson K, Stolzenberg-Solomon R, et al